One of the biggest challenges for people living with diabetes is the sheer burden of managing their diseases within day to day life; the endless measurement, the injections, the planning. It’s the thinking that exhausts people. There’s no holiday from diabetes; no time-out; no pause button.
That is why I am delighted to see that a number of EFPIA member companies have come together to launch the EFPIA Diabetes Platform with a simple aim: To be an active partner in the fight against diabetes, improving the lives of everyone affected by the disease.Read more
The EMA 2018 annual report provides an overview of the Agency’s activities to protect and promote the health of people...
Read more
About the EFPIA newsletter
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.